Charles Schwab’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $22M | Buy |
|
|||||
|
2023
Q1 | $18.8M | Buy |
|
|||||
|
2022
Q4 | $7.83M | Buy |
|
|||||
|
2022
Q3 | $5.09M | Buy |
|
|||||
|
2022
Q2 | $5.93M | Sell |
|
|||||
|
2022
Q1 | $6.56M | Buy |
|
|||||
|
2021
Q4 | $5.11M | Buy |
|
|||||
|
2021
Q3 | $19.2M | Buy |
|
|||||
|
2021
Q2 | $26.3M | Buy |
|
|||||
|
2021
Q1 | $12.6M | Sell |
|
|||||
|
2020
Q4 | $16.2M | Buy |
|
|||||
|
2020
Q3 | $11.5M | Sell |
|
|||||
|
2020
Q2 | $20.4M | Sell |
|
|||||
|
2020
Q1 | $23.5M | Buy |
|
|||||
|
2019
Q4 | $30.7M | Buy |
|
|||||
|
2019
Q3 | $10.7M | Buy |
|
|||||
|
2019
Q2 | $9.56M | Buy |
|
|||||
|
2019
Q1 | $8.23M | Buy |
|
|||||
|
2018
Q4 | $5.13M | Sell |
|
|||||
|
2018
Q3 | $7.5M | Buy |
|
|||||
|
2018
Q2 | $2.47M | Buy |
|
|||||
|
2018
Q1 | $1.01M | Buy |
|
|||||
|
2017
Q4 | $1.36M | Sell |
|
|||||
|
2017
Q3 | $1.55M | Buy |
|
|||||
|
2017
Q2 | $861K | Buy |
|
|||||
|
2017
Q1 | $426K | Hold |
|
|||||
|
2016
Q4 | $411K | Buy |
|
|||||
|
2016
Q3 | $240K | Buy |
|